153 related articles for article (PubMed ID: 34130602)
1. Mixed chimerism after allogeneic hematopoietic stem cell transplantation for severe aplastic anemia.
Zhang Y; Li Y; Wu L; Zhou M; Wang C; Mo W; Chen X; Xu S; Zhou R; Wang S; Zhang Y
Hematology; 2021 Dec; 26(1):435-443. PubMed ID: 34130602
[TBL] [Abstract][Full Text] [Related]
2. [A comparative study of unrelated donor and matched-sibling donor allogeneic hematopoietic stem cell transplantation in children and adolescents with acquired severe aplastic anemia].
Zhou J; Fu YW; Liang LJ; Wang Q; Han LJ; Zu YL; Zhang Y; Zhu XH; Yu FK; Fang BJ; Wei XD; Song YP
Zhonghua Nei Ke Za Zhi; 2016 Dec; 55(12):927-931. PubMed ID: 27916046
[No Abstract] [Full Text] [Related]
3. Mixed Chimerism and Secondary Graft Failure in Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia.
Kako S; Yamazaki H; Ohashi K; Ozawa Y; Ota S; Kanda Y; Maeda T; Kato J; Ishiyama K; Matsuoka KI; Miyamoto T; Iida H; Ikegame K; Fukuda T; Ichinohe T; Atsuta Y; Mori T;
Biol Blood Marrow Transplant; 2020 Mar; 26(3):445-450. PubMed ID: 31618688
[TBL] [Abstract][Full Text] [Related]
4. [Outcomes of allogeneic hematopoietic stem cell transplantation in patients with paroxysmal nocturnal hemoglobinuria compared to paroxysmal nocturnal hemoglobinuria-aplastic anemia syndrome].
Liu LM; Zhou HF; Wang QY; Qiu HY; Tang XW; Han Y; Fu CC; Jin ZM; Chen SN; Sun AN; Miao M; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2019 Jun; 40(6):472-476. PubMed ID: 31340619
[No Abstract] [Full Text] [Related]
5. The incidence, clinical outcome, and protective factors of mixed chimerism following hematopoietic stem cell transplantation for severe aplastic anemia.
Xu ZL; Cheng YF; Zhang YY; Mo XD; Han TT; Wang FR; Yan CH; Sun YQ; Chen YH; Tang FF; Han W; Wang Y; Zhang XH; Liu KY; Huang XJ; Xu LP
Clin Transplant; 2021 Feb; 35(2):e14160. PubMed ID: 33222318
[TBL] [Abstract][Full Text] [Related]
6. Effect of Donor Lymphocyte Infusion From Two Types of Donors on Mixed Chimerism With Secondary Graft Failure After Allogeneic Hematopoietic Stem Cell Transplantation.
Ren RR; Ma LM; Xie YX; Tian WW; Wang T
Transplant Cell Ther; 2022 Mar; 28(3):152.e1-152.e7. PubMed ID: 34973501
[TBL] [Abstract][Full Text] [Related]
7. Combination of HLA-Matched Sibling Allogeneic Hematopoietic Stem Cell Transplantation With Unrelated Cord Blood Unit in Patients Aged 35 to 50 Years With Severe Aplastic Anemia: Preliminary Summary of a Single-Arm Trial.
Yang Y; Xu H; He H; Qi J; Yan J; Wang N; Huang D
Transplant Proc; 2019 Dec; 51(10):3431-3436. PubMed ID: 31733793
[TBL] [Abstract][Full Text] [Related]
8. Impact of Day 14 Peripheral Blood Chimerism after Allogeneic Hematopoietic Stem Cell Bone Transplantation on the Treatment Outcome of Non-Malignant Disease.
Choi YB; Lee JW; Sung KW; Koo HH; Kim HJ; Yoo KH
J Korean Med Sci; 2019 Feb; 34(6):e46. PubMed ID: 30787679
[TBL] [Abstract][Full Text] [Related]
9. [Outcome of allogeneic hematopoietic stem cell transplantation from HLA-matched sibling donor for 41 cases of severe aplastic anemia].
Chen X; Wei JL; Huang Y; He Y; Yang DL; Jiang EL; Ma QL; Zhou LK; Lin XT; Shen YY; Feng SZ; Han MZ
Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):610-4. PubMed ID: 23134851
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic Hematopoietic Stem Cell Transplant for Severe Aplastic Anemia: Current State and Future Directions.
Sun Q; Wu B; Zhu Z; Sun C; Xu J; Long H; Huang Y; Xu J; Song C
Curr Stem Cell Res Ther; 2018; 13(5):350-355. PubMed ID: 28245775
[TBL] [Abstract][Full Text] [Related]
11. Mixed T Cell Chimerism After Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia Using an Alemtuzumab-Containing Regimen Is Shaped by Persistence of Recipient CD8 T Cells.
Grimaldi F; Potter V; Perez-Abellan P; Veluchamy JP; Atif M; Grain R; Sen M; Best S; Lea N; Rice C; Pagliuca A; Mufti GJ; Marsh JCW; Barber LD
Biol Blood Marrow Transplant; 2017 Feb; 23(2):293-299. PubMed ID: 27816648
[TBL] [Abstract][Full Text] [Related]
12. Serial chimerism analyses indicate that mixed haemopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indication for routine assessment of chimerism post SCT for SAA.
Lawler M; McCann SR; Marsh JC; Ljungman P; Hows J; Vandenberghe E; O'Riordan J; Locasciulli A; Socié G; Kelly A; Schrezenmeier H; Marin P; Tichelli A; Passweg JR; Dickenson A; Ryan J; Bacigalupo A;
Br J Haematol; 2009 Mar; 144(6):933-45. PubMed ID: 19183198
[TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of formation and conversion of hematopoietic mixed chimerism in nonmyeloablative allogeneic stem cell transplantation].
Ai HS; Yu CL; Wang DH; Guo M; Qiao JH; Shi BF; Sun WJ; Zhang S; Sun QY; Yao B
Zhonghua Yi Xue Za Zhi; 2003 Feb; 83(3):208-11. PubMed ID: 12812663
[TBL] [Abstract][Full Text] [Related]
14. Effect of Antithymocyte Globulin Source on Outcomes of HLA-Matched Sibling Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Severe Aplastic Anemia.
Chen X; Wei J; Huang Y; He Y; Yang D; Zhang R; Jiang E; Ma Q; Zhai W; Yao J; Zhang G; Feng S; Han M
Biol Blood Marrow Transplant; 2018 Jan; 24(1):86-90. PubMed ID: 29032265
[TBL] [Abstract][Full Text] [Related]
15. [Hematopoietic Reconstitution and Prognosis of HLA Matched and Haploidentical Hematopoietic Stem Cell Transplantation Using Modified FC/ATG Conditioning for Treatment of Severe Aplastic Anemia].
Wang L; Wu YM; Cao YB; Li XH; Xu LX; Wang HT; Gao YH; Wu XX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Dec; 24(6):1817-1823. PubMed ID: 28024500
[TBL] [Abstract][Full Text] [Related]
16. Donor-Host Lineage-Specific Chimerism Monitoring and Analysis in Pediatric Patients Following Allogeneic Stem Cell Transplantation: Influence of Pretransplantation Variables and Correlation with Post-Transplantation Outcomes.
Llaurador G; Nicoletti E; Prockop SE; Hsu S; Fuller K; Mauguen A; O'Reilly RJ; Boelens JJ; Boulad F
Transplant Cell Ther; 2021 Sep; 27(9):780.e1-780.e14. PubMed ID: 34082161
[TBL] [Abstract][Full Text] [Related]
17. [Outcomes of allogeneic hematopoietic stem cell transplantation for 18 patients with paroxysmal nocturnal haemoglobinuria].
Chen F; Wu D; Tang X; Miao M; Fu C; Qiu H; Jin Z; Xue S; Ma X; Sun A; Chang W; Ruan C
Zhonghua Xue Ye Xue Za Zhi; 2015 Dec; 36(12):1005-10. PubMed ID: 26759101
[TBL] [Abstract][Full Text] [Related]
18. A combination of fludarabine, half-dose cyclophosphamide, and anti-thymocyte globulin is an effective conditioning regimen before allogeneic stem cell transplantation for aplastic anemia.
Ashizawa M; Akahoshi Y; Nakano H; Ugai T; Wada H; Yamasaki R; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Terasako K; Kimura S; Kikuchi M; Nakasone H; Kako S; Kanda J; Yamazaki R; Tanihara A; Nishida J; Kanda Y
Int J Hematol; 2014 Mar; 99(3):311-7. PubMed ID: 24488782
[TBL] [Abstract][Full Text] [Related]
19. Development of hemolytic paroxysmal nocturnal hemoglobinuria without graft loss following hematopoietic stem cell transplantation for acquired aplastic anemia.
Oved JH; Stanley N; Babushok DV; Huang Y; Duke JL; Monos DS; Teachey DT; Olson TS
Pediatr Transplant; 2019 Jun; 23(4):e13393. PubMed ID: 30900367
[TBL] [Abstract][Full Text] [Related]
20. Matched sibling versus matched unrelated allogeneic hematopoietic stem cell transplantation in children with severe acquired aplastic anemia: experience of the polish pediatric group for hematopoietic stem cell transplantation.
Szpecht D; Gorczyńska E; Kałwak K; Owoc-Lempach J; Choma M; Styczyński J; Goździk J; Dłużniewska A; Wysocki M; Kowalczyk JR; Chybicka A; Pieczonka A; Wachowiak J
Arch Immunol Ther Exp (Warsz); 2012 Jun; 60(3):225-33. PubMed ID: 22527354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
